Sjögren's disease & overlap diseases

Kynurenines and neopterin are interferon-gamma-inducible biomarkers for Sjögren’s disease

Rheumatology (Oxford)Published Case-control study

Authors' conclusion

Kynurenines and neopterin are interferon-gamma-inducible biomarkers associated with more chances for SjD and with disease activity, glandular dysfunction, autoantibodies and immunological and inflammatory biomarkers.

Study context

Population
Sjögren's disease (SjD) patients and age- and sex-matched healthy volunteers
Participants
97 vs 63
Comparison
SjD patients vs age- and sex-matched healthy volunteers
  • SjDn = 97
  • Healthy volunteersn = 63reference
Outcome
Whether kynurenine pathway metabolites and neopterin increase probability for SjD
Methodological detailsage- and sex-matched healthy volunteers
  • Age- and sex-matched healthy volunteers

Main finding

As reported in the abstract

Kynurenine pathway metabolites, neopterin and probability of SjD
Each group vs healthy volunteersEstimate (95% CI)
SjD
OR (kynurenine) 2.51(1.44–5.64)
SjD
OR (KTR) 3.45(1.76–6.74)
SjD
OR (neopterin) 4.28(1.95–9.42)
SjD
OR (vitamin B6 metabolite PAr) 3.34(1.19–9.39)
Tryptophan lower in SjD
P = 0.012
Kynurenine higher in SjD
P = 0.005
Kynurenine/tryptophan ratio (KTR) higher in SjD
P = 0.001
Neopterin higher in SjD
P = 0.02

Observational data: associations, not effects.

Further findings

Associations with clinical parameters

Kynurenine, KTR, neopterin and PAr associated with disease activity, longer disease duration, depression, impaired salivary flow, hypergammaglobulinemia, neutropenia, hypocomplementemia and positive anti-Ro/SSA and anti-La/SSB

Associations with inflammatory biomarkers

Neopterin correlated with kynurenines; both associated with PAr and pro-inflammatory cytokines, mainly TNF-α, IL-1β and TNF receptors I and II

Original publication

Kynurenines and neopterin are interferon-gamma-inducible biomarkers for Sjögren’s disease. Rheumatology (Oxford). Published 25 April 2025. doi:10.1093/rheumatology/keaf158

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.